Worksoft Introduces Process Intelligence with AI-Powered Analytics to its Codeless Connective Automation Platform
New Capabilities Deliver Real-Time Process Understanding to Market’s Only Automation Platform Seamlessly Connecting Process Intelligence, Testing and RPA
DALLAS, April 06, 2021 (GLOBE NEWSWIRE) -- Worksoft, the industry’s leading provider of end-to-end enterprise automation for complex custom and packaged applications like SAP, Oracle, Salesforce, Workday and more, today announced the expansion of its Connective Automation Platform to include unmatched AI-driven analytics capabilities, becoming the first vendor to offer a genuinely codeless, scalable automation solution that seamlessly connects process intelligence, business process testing and production automation to drive comprehensive process insight and continuous process improvement.
Process Intelligence provides a unified view of end-to-end business processes with actionable insights, delivering unprecedented enterprise process visibility and maximizing process efficiency by eliminating business and IT silos. Combining multiple data sources—including process mining, business process captures, test automation results, production performance, and more—Process Intelligence generates a real-time roadmap for automation and process optimization.
“This new level of Process Intelligence is a catalyst for CFOs and CIOs looking to unlock the full potential of their automation investment, providing them with a closed-loop view of their processes in real-time,” said Tony Sumpster, Worksoft CEO. “Process understanding is critical to driving digital transformation, and these platform enhancements reinforce our commitment to enabling real business change, uniquely bridging process understanding and business process automation in pre and post-production.”
Digital transformation and automation strategies heighten the need to identify and understand business processes. The addition of Process Intelligence to Worksoft’s Connective Automation platform creates an unparalleled opportunity for enterprises to visualize and understand as-is business processes and identify and create resilient automation to enable continuous testing, RPA and Agile+DevOps development initiatives at speed and scale.
“Worksoft’s AI-powered process intelligence is transforming the way business and IT teams align to deliver the best end-user experience and business outcomes. It provides real-time automation insights enabling customers to better understand, de-risk, and optimize their processes,” said Shoeb Javed, Worksoft Chief Product and Strategy Officer. “With nearly three-quarters of organizations today having adopted DevOps in some form, the request for advanced automation and deeper business/IT alignment is accelerating. Our platform now offers customers the ability to continuously evaluate process insights to target what to automate and build automation at scale, faster.”
Key Process Intelligence Benefits:
- Real-time ROI – Identifies candidates for process optimization and automation, prioritized by potential and realized cost savings to extend existing automation value to prove immediate impact.
- Closed-Loop Automation – Uses AI-driven Process Intelligence to turn insights into automation and process optimization at the click of a button.
- 360-Degree Insights – Unifies real-time business and IT data insights from the broadest sources to deliver the best end-user experience and business outcomes.
Process Intelligence Customer Beta Quotes:
“With Process Intelligence, it’s easy to view optimization and automation opportunities across all of my process data.” – IT Specialist for industry-leading consumer packaged goods manufacturer
“Process Intelligence gives me a one-screen, easy-to-use view of what I’ve automated and where I need to focus across my landscape.” – QA Manager for leading HVAC and building supplies manufacturer
About Worksoft
Worksoft provides Connective Automation for the world’s leading global enterprises, automating the full lifecycle of a business process from process intelligence to testing to RPA. Our codeless automation empowers business users and IT to accelerate automation and arms organizations with process data insights to prioritize automation efforts and extend the value into RPA for maximum efficiency and scalability. With Worksoft, enterprises can speed project timelines and ensure data-driven quality for their complex end-to-end business applications, including SAP, Oracle, Salesforce, Workday®, SuccessFactors, ServiceNow, and more. Recognized by leading Global Systems Integrators as the market’s choice for large-scale continuous enterprise automation, Worksoft is embedded into their ERP practices to enable their Agile, DevOps, and SAFe methodologies and accelerate digital transformation.
For more information, contact Worksoft at info@worksoft.com or visit www.worksoft.com. For media inquiries, contact Liz Blackman, eblackman@worksoft.com, or +1 (806) 438-0556.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/1636d3a1-c45d-4ac1-b12d-9e9176c899a4
About GlobeNewswire
GlobeNewswireGlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
iTeos Therapeutics Announces New Preliminary Data Indicating Clinical Activity with its Anti-TIGIT Antibody, EOS-448, at the AACR Annual Meeting 202110.4.2021 14:30:00 CEST | Press release
Initial data from the Phase 1 dose escalation part of the Phase 1/2a trial in adult patients with advanced solid tumors indicated EOS-448 was generally well tolerated with no dose-limiting toxicities observed EOS-448 showed preliminary signs of clinical activity as a monotherapy, including a partial response in one pembrolizumab-resistant melanoma patient, and stable disease in multiple patients EOS-448 reduced TIGIT+ suppressive T regulatory cells and CD8 T cells considered to be exhausted at all tested doses, indicating engagement of FcγR, an essential component in many immune system effector functions Company to advance EOS-448 into combination trials with pembrolizumab and other novel agents in both checkpoint-naïve and resistant patients Company to host conference call on Monday, April 12th at 8:00 a.m. EDT to discuss results CAMBRIDGE, Mass. and GOSSELIES, Belgium, April 10, 2021 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), clinical-stage biopharmaceutical company
Notice to Annual General Meeting 20219.4.2021 21:45:00 CEST | Press release
Shareholders in MICRO SYSTEMATION AB (publ) are hereby given notice to attend the Annual General Meeting (AGM) on Tuesday, 11 May 2021, at 18.00 at MSAB’s premises at Hornsbruksgatan 28 in Stockholm. Registration for the AGM will commence at 17:15. Because of COVID-19 (the Corona virus), MSAB is prioritising health and safety and has thus decided to hold the AGM on Company premises, Hornsbruksgatan 28 in Stockholm, and keep the meeting as brief as possible and to provide the opportunity for shareholders to also vote by post. No food will be served. The demonstration and display of the Company’s products normally given in conjunction with the AGM are cancelled. Questions for Company management can be sent to info@msab.com. Against the backdrop of recommendations issued by Swedish authorities, all shareholders are encouraged to consider utilising the possibility of voting by mail via a form which will be available on the Company’s website (www.msab.com/investors) rather than physically a
Kallelse till årsstämma 20219.4.2021 21:45:00 CEST | Pressemelding
Aktieägare i MICRO SYSTEMATION AB (publ) kallas härmed till årsstämma tisdagen den 11 maj 2021 kl. 18.00 i MSABs lokaler på Hornsbruksgatan 28 i Stockholm. Inregistrering till årsstämman börjar klockan 17:15. Med anledning av COVID-19 (Corona-viruset) har MSAB, för att sätta hälsa och säkerhet i första rummet, beslutat att hålla stämman i bolagets lokaler, Hornsbruksgatan 28 i Stockholm och att korta stämman så långt som möjligt, samt ge aktieägarna möjlighet att före stämman utöva sin rösträtt per post. Någon servering kommer inte att förekomma. Demonstration och visning av bolagets produkter som normalt görs i samband med stämman är inställd. Frågor till bolagsledningen kan skickas till info@msab.com . Mot bakgrund av myndigheternas föreskrifter uppmanas alla aktieägare att överväga att istället för att närvara fysiskt vid stämman utnyttja möjligheten att poströsta via formulär på bolagets hemsida www.msab.com/investors. RÄTT TILL DELTAGANDE Aktieägare i Micro Systemation AB (publ),
RomReal: Mandatory notification of insider trade - Chairman and CEO of RomReal Kjetil Gronskag9.4.2021 18:43:18 CEST | Press release
Kjetil Gronskag, Chairman and CEO of RomReal Ltd has today 09 April 2021, purchased 9 shares of RomReal at NOK 1.75 per share in RomReal Ltd. Following this trade, Kjetil Gronskag controls privately and through holding companies 4,475,739 shares in RomReal Ltd. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
CONDITIONS FOR PURCHASES OF CORPORATE BONDS9.4.2021 16:20:00 CEST | Press release
Bid procedure, 2021-04-14BondsBonds issued in SEK by Swedish non-financial undertakings. The following bonds are eligible for delivery: VATTENFALL AB: XS0328561286, 2022-11-01 STANGASTADEN AB: SE0012193860, 2024-09-27 HEBA FASTIGHETS AB: SE0013882875, 2026-03-02 SWEDISH MATCH AB: XS1619638528, 2022-05-30 SWEDISH MATCH AB: XS2306815114, 2026-02-24 SVENSKA CELLULOSA AB SCA: SE0013882560, 2025-09-23 Delivery of a Bond may not occur if the Counterparty has purchased the Bond from the issuer more recently than one month prior to the date of announcement of the Special terms, that is, the purchase may not have taken place after: 2021-03-14Bid date2021-04-14Bid times10.00-11.00 (CET/CEST) on the Bid dateRequested volume (corresponding nominal amount)XS0328561286: 30 mln SEK +/-30 mln SEK SE0012193860: 30 mln SEK +/-30 mln SEK SE0013882875: 30 mln SEK +/-30 mln SEK XS1619638528: 30 mln SEK +/-30 mln SEK XS2306815114: 30 mln SEK +/-30 mln SEK SE0013882560: 30 mln SEK +/-30 mln SEK Highest permi
CONDITIONS FOR THE RIKSBANK´S PURCHASES OF COMMERCIAL PAPER9.4.2021 16:20:00 CEST | Press release
Bid procedure, 2021-04-14CertificateCommercial paper issued in SEK by non-financial companies with their registered office in Sweden and with a remaining maturity of up to six months on the Bid date. i.e. with the latest maturity date as of 2021-10-14 Delivery may not be made in commercial paper purchased by the Counterparty from the issuer less than one week prior to the date for announcing the Special terms, i.e. the purchase may not have been made after 2021-04-02 BidsCounterparties may make one bid per Credit rating class and maturity class. Bids are made to tel 08-696 69 70 and confirmed by e-mail to EOL@riksbank.se.Bid date2021-04-14Bid times09.00-09.30 (CET/CEST) on the Bid dateRequested volume (corresponding nominal amount)SEK 4 billionHighest permitted bid volume (corresponding nominal amount)The total bid volume from one Counterparty for the two Credit rating classes may not exceed SEK 4 billion. No bid may contain Commercial paper in excess of SEK 250 million issued by the s
CONDITIONS FOR RIKSBANK REVERSED AUCTIONS SEK GOVERNMENT BONDS9.4.2021 16:20:00 CEST | Press release
Bid procedure, 2021-04-16BondsSWEDISH GOVERNMENT: 1062. SE0013935319. 2031-05-12 SWEDISH GOVERNMENT: 1053, SE0002829192, 2039-03-30 KINGDOM OF SWEDEN: REGS, XS2226974504, 2030-09-09 Bid date2021-04-16Bid times09.00-10.00 (CET/CEST) on the Bid dateRequested volume (corresponding nominal amount)1062: 750 mln SEK +/-400 mln SEK 1053: 500 mln SEK +/-250 mln SEK REGS: 250 mln SEK +/-250 mln SEK Highest permitted bid volume (corresponding nominal amount)1062: 750 mln SEK per bid 1053: 500 mln SEK per bid REGS: 250 mln SEK per bid Lowest permitted bid volume (corresponding nominal amount)SEK 50 million per bidExpected allocation timeNot later than 10.15 (CET/CEST) on the Bid dateDelivery and payment date2021-04-20Delivery of bondsTo the Riksbank's account in Euroclear Sweden AB's securities settlement system 1 4948 6383 Stockholm, 2021-04-09 This is a translation of the special terms and conditions published on www.riksbank.se. In the case of any inconsistency between the English translation